Indications and Purposes
| 1 Indications And Usage Alunbrig Is Indicated For The Treatment Of Adult Patients With Anaplastic Lymphoma Kinase (Alk)-Positive Metastatic Non-Small Cell Lung Cancer (Nsclc) As Detected By An Fda-Approved Test [See Dosage And Administration (2.1) ]. Alunbrig Is A Kinase Inhibitor Indicated For The Treatment Of Adult Patients With Anaplastic Lymphoma Kinase (Alk)-Positive Metastatic Non-Small Cell Lung Cancer (Nsclc) As Detected By An Fda-Approved Test. ( 1 , 2.1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Brigatinib |